Accord Sees Benefits From Unique Portfolio
EMENA Chief Paul Tredwell Talks About How The Firm Views Its Broad Offering
With Accord boasting a broad portfolio that encompasses generics, biosimilars, hybrid medicines and specialty products, Paul Tredwell – the firm’s executive vice-president for the Europe, Middle East and North Africa region – explains how this gives the company a unique position in the market.
